Rockefeller Capital Management L.P. Nuvasive Inc Transaction History

Rockefeller Capital Management L.P.

$33.9 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$42.51 - $54.02 $1,062 - $1,350	-25 Reduced 1.73%	1,419 $62,000
Q2 2022 Aug 12, 2022	SELL	$46.84 - $59.75 $24,263 - $30,950	-518 Reduced 26.4%	1,444 $70,000
Q1 2022 May 13, 2022	SELL	$48.09 - $57.79 $6,973 - $8,379	-145 Reduced 6.88%	1,962 $111,000
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $8,541 - $11,345	181 Added 9.4%	2,107 $110,000
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $28,625 - $34,108	503 Added 35.35%	1,926 $115,000

Q2 2021 Aug 10, 2021	BUY	$64.02 - $71.72 $704 - $788	11 Added 0.78%	1,423 $96,000
Q1 2021 May 11, 2021	SELL	$53.26 - $68.08 $2,183 - $2,791	-41 Reduced 2.82%	1,412 $92,000
Q4 2020 Feb 12, 2021	BUY	$43.41 - $56.51 $4,167 - $5,424	96 Added 7.07%	1,453 $81,000
Q3 2020 Nov 13, 2020	SELL	$47.43 - $60.75 $2,086 - $2,673	-44 Reduced 3.14%	1,357 $65,000
Q2 2020 Aug 12, 2020	SELL	$43.51 - $66.59 $826 - $1,265	-19 Reduced 1.34%	1,401 $78,000
Q1 2020 May 12, 2020	SELL	$32.82 - $81.13 $7,187 - $17,767	-219 Reduced 13.36%	1,420 $72,000
Q4 2019 Feb 07, 2020	BUY	$60.96 - $77.7 $853 - $1,087	14 Added 0.86%	1,639 $127,000
Q3 2019 Nov 12, 2019	BUY	$55.78 - $68.08 $3,067 - $3,744	55 Added 3.5%	1,625 $103,000
Q2 2019 Aug 09, 2019	SELL	$53.69 - $65.47 $23,194 - $28,283	-432 Reduced 21.58%	1,570 $92,000
Q1 2019 May 10, 2019	BUY	$44.53 - $58.9 $63,766 - $84,344	1,432 Added 251.23%	2,002 $114,000
Q4 2018 Feb 12, 2019	BUY	$47.64 - $71.26 $27,154 - $40,618	570 New	570 $28,000
Q2 2018 Jul 31, 2018	SELL	$48.15 - $56.68 $130,486 - $153,602	-2,710 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$46.03 - $61.28 $124,741 - $166,068	2,710 New	2,710 $141,000

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account